A detailed history of Mc Lean Asset Management Corp transactions in Abb Vie Inc. stock. As of the latest transaction made, Mc Lean Asset Management Corp holds 2,914 shares of ABBV stock, worth $573,533. This represents 0.16% of its overall portfolio holdings.

Number of Shares
2,914
Previous 2,821 3.3%
Holding current value
$573,533
Previous $480 Million 2.08%
% of portfolio
0.16%
Previous 0.16%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 11, 2024

BUY
$154.79 - $180.76 $14,395 - $16,810
93 Added 3.3%
2,914 $490 Million
Q1 2024

Apr 10, 2024

BUY
$159.82 - $182.1 $3,835 - $4,370
24 Added 0.86%
2,821 $480 Million
Q4 2023

Jan 08, 2024

SELL
$137.6 - $154.97 $21,603 - $24,330
-157 Reduced 5.31%
2,797 $454 Million
Q3 2023

Oct 11, 2023

BUY
$133.59 - $154.65 $28,053 - $32,476
210 Added 7.65%
2,954 $440 Million
Q2 2023

Jul 10, 2023

SELL
$132.51 - $164.9 $22,129 - $27,538
-167 Reduced 5.74%
2,744 $370 Million
Q1 2023

Apr 11, 2023

SELL
$144.61 - $166.54 $60,013 - $69,114
-415 Reduced 12.48%
2,911 $464 Million
Q4 2022

Jan 19, 2023

BUY
$138.31 - $165.87 $35,822 - $42,960
259 Added 8.44%
3,326 $538 Million
Q3 2022

Oct 12, 2022

SELL
$134.21 - $153.93 $8,589 - $9,851
-64 Reduced 2.04%
3,067 $426,000
Q2 2022

Jul 07, 2022

BUY
$137.62 - $174.96 $14,450 - $18,370
105 Added 3.47%
3,131 $478,000
Q1 2022

Apr 08, 2022

SELL
$131.98 - $163.75 $12,802 - $15,883
-97 Reduced 3.11%
3,026 $491,000
Q4 2021

Jan 14, 2022

SELL
$107.43 - $135.93 $47,806 - $60,488
-445 Reduced 12.47%
3,123 $429,000
Q3 2021

Oct 27, 2021

BUY
$106.4 - $120.78 $121,402 - $137,809
1,141 Added 47.01%
3,568 $391,000
Q2 2021

Jul 19, 2021

BUY
$105.21 - $117.21 $14,308 - $15,940
136 Added 5.94%
2,427 $285,000
Q1 2021

Apr 28, 2021

BUY
$102.3 - $112.62 $8,695 - $9,572
85 Added 3.85%
2,291 $255,000
Q4 2020

Jan 27, 2021

BUY
$80.49 - $108.67 $177,560 - $239,726
2,206 New
2,206 $236,000

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $348B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Mc Lean Asset Management Corp Portfolio

Follow Mc Lean Asset Management Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Mc Lean Asset Management Corp, based on Form 13F filings with the SEC.

News

Stay updated on Mc Lean Asset Management Corp with notifications on news.